- Solutions
Our solutions
- OverviewOur workflow solutions give you the data, tools, and insights to power every decision
- Strategic IntelligenceGet a complete view of strategic issues and stay ahead of emerging disruptive themes
- Sales IntelligenceOur workflow solutions give you the data, tools, and insights to power every decision
- Industry
- Platform
Our platform
Your powerful intelligence platform
Explore the fully comprehensive productivity and insights platform
- Company
We are GlobalData
With the rising incidence of prostate cancer in Australia, there is a growing need for accurate and timely diagnostic methods. As a result, the use of PET imaging and SPECT imaging agents is likely to rise over the next few years. The surge in precision diagnostics, bolstered by heightened awareness among healthcare professionals and proactive […]
GeneCentric’s funding highlights growing investor interest in RNA-driven diagnostics in precision oncology, says GlobalData
GeneCentric Therapeutics has recently secured $8 million in new funding to advance its RNA-based liquid biopsy platform. The financing will support the development and commercialization of GeneCentric’s platform, which enables non-invasive tumor profiling to guide treatment decisions and monitor disease progression. The funding reflects the growing investor enthusiasm for RNA-driven diagnostics in precision oncology, according […]
Penumbra to gain market share in peripheral embolization coils with Ruby XL system, says GlobalData
Penumbra has announced FDA approval for its Ruby XL system, which includes three coils; Ruby XL, POD XL, and Packing Coil XL. The Ruby XL coil can be used to frame large aneurysms. The POD XL is designed for use in high flow vessels. The Packing Coil XL is designed to adjust to the shape […]
India dialysis machines market to grow at 2% CAGR through 2036, forecasts GlobalData
With chronic kidney disease (CKD) cases steadily rising across India, particularly in semi-urban and rural areas, the need for affordable and advanced dialysis treatment is more urgent than ever. Against this backdrop, the dialysis machines market in India is projected to grow at a 2% compound annual growth rate (CAGR) during 2025-36, according to GlobalData, […]
Japan diagnostic imaging market poised for 2% CAGR through 2034, forecasts GlobalData
Japan’s diagnostic imaging sector is undergoing significant transformation, with cutting-edge technologies that are re-defining capabilities across techniques such as CT, MRI, ultrasound, and breast imaging. Against this backdrop, the country’s diagnostic imaging market is projected to expand at a compound annual growth rate (CAGR) of 2% through 2034, forecasts GlobalData, a leading data and analytics […]
US HPV testing market shielded from tariffs but export risks for domestic makers remain, reveals GlobalData
The US human papillomavirus (HPV) testing market will remain unaffected by the Trump Administration’s tariffs, as the leading tests—Roche’s cobas and Hologic’s Aptima Panther—are entirely manufactured within the country. With 94.6% of HPV tests produced within the country, the risk of cost increases or supply chain disruptions is minimal. However, export challenges may arise for […]
US cardiovascular device market under threat from tariffs, says GlobalData
US medical device companies continue to face uncertainty and instability as President Donald Trump’s tariffs continue to disrupt the market. Major manufacturers are currently most concerned with supply chain interruptions and cost increases, leading to constant adjustments of company forecasts. Cardiovascular devices are especially vulnerable to the impacts of tariffs, as many of these devices […]
Abbott and Medtronic best positioned manufacturers in US neurology market, says GlobalData
As US tariff policies evolve in 2025, neurology device manufacturers face rising cost pressures and growing uncertainty over production strategy. However, Abbott and Medtronic are best positioned among top competitors, with majority of their 510(k)-approved neurology devices manufactured exclusively in the US, respectively, according to the MedSource Database of GlobalData, a leading data and analytics […]
GlobalData highlights impact of US tariffs on medical robotics industry
The US government’s imposition of new tariffs in 2025 marks a significant shift in trade policy that has wide-reaching implications across multiple sectors, including healthcare. Among the most affected segments is the medical robotics industry, a high-growth field that blends precision engineering, artificial intelligence (AI), and life-saving applications in surgery and diagnostics. While tariffs are […]
Pulsed field ablation devices face growth challenges as US tariffs disrupt cardiovascular market, says GlobalData
The US cardiovascular devices market is facing growing challenges as President Trump’s tariffs disrupt global supply chains and worsen international relations. Particularly, pulsed field ablation (PFA) devices, often manufactured abroad for cost, efficiency, and material access, are now subject to higher tariffs. This disruption could slow the significant growth seen in the sector in recent […]
GlobalData highlights tariff implications on nephrology and urology market
The Trump Administration’s tariffs on most US trading partners are expected to impact all 510(k)-approved medical devices manufactured outside of the US (OUS). Thus, companies with OUS manufacturing will be affected by tariffs, while companies that exclusively manufacture in the US will not be impacted. Therefore, to remain competitive in the US market, nephrology and […]
Tariffs to push healthcare facilities to stock up medical devices, says GlobalData
With the surge in tariffs imposed by and on the US, the medical device industry is likely to be impacted in several areas. Cost, supply chain, and market competitiveness will be altered if companies cannot afford to offset tariff costs. In response to medical device companies, healthcare facilities may stock up on medical devices to […]
South Korea PCR systems market to grow at 4% CAGR through 2036, forecasts GlobalData
As South Korea continues to strengthen its healthcare infrastructure in the face of emerging infectious diseases, the role of advanced diagnostics has become more critical than ever. Against this background, the market for Polymerase Chain Reaction (PCR) systems in South Korea is projected to grow at a 4% compound annual growth rate (CAGR) during 2025-36, […]
Mammography equipment market in South Korea to grow at 4% CAGR through 2036, forecasts GlobalData
The market for mammography equipment in South Korea is undergoing significant growth. This upsurge is attributable to the broadening scope of breast cancer screening initiatives, increased public awareness, and the incorporation of sophisticated imaging technologies. Owing to these factors, the mammography equipment market in South Korea is set to grow at a compound annual growth […]
US structural heart occlusion market sees early 2025 growth amid trade uncertainty, says GlobalData
The US Structural Heart Occlusion (SHO) market posted a notable 39% year-over-year revenue increase in Q1 2025, amid heightened trade policy uncertainty following President Donald Trump’s re-election and the swift introduction of new tariff measures in early 2025, according to GlobalData, a leading data and analytics company. Trump’s new tariff regime includes a 10% global […]
Mycobacterium tuberculosis tests market in Japan to grow at 4% CAGR through 2036, forecasts GlobalData
As one of the world’s deadliest infectious diseases, tuberculosis (TB) continues to pose a significant global health challenge, especially in low-resource settings, where the lack of timely, accurate, and accessible diagnostics hampers eradication efforts. Against this backdrop, the Mycobacterium tuberculosis tests market in Japan is projected to achieve substantial growth, with an anticipated compound annual […]
US medical device companies show diverging paths on tariff strategy, says GlobalData
The Trump administration’s 2025 trade agenda is compelling US medical device companies to address escalating tariff pressures, especially those on imports from China. While some are making decisive shifts in their manufacturing strategies, others are conservatively absorbing short-term impacts and awaiting tariff stabilization. As such, firms must carefully evaluate the long-term risks of trade disruption […]
Australia digital health market to grow at 8% CAGR through 2034, forecasts GlobalData.
The digital health market in Australia is set for expansion. This growth reflects the increasing integration of digital technologies into healthcare and rising demand for more accessible, efficient, and personalized medical services. With these factors in play, the digital health market in Australia is set to grow at compound annual growth rate (CAGR) of approximately […]
GlobalData highlights potential impact of US tariffs on medical tourism
US trade policy has seen notable changes recently, particularly with regard to import tariffs on countries such as China. Though these policies are usually justified by economic and geopolitical considerations, they also impact other areas, including the medical device industry and, more specifically, medical tourism. One growing outcome is how these tariffs are affecting medical […]
US tariffs could accelerate supply chain diversification in medtech sector, says GlobalData
The US Trade Representative’s (USTR) plan to reinstate Section 301 tariffs targets Class I and II medical devices, including orthopedic instruments frequently sourced from China. The move is expected to lead to a rise in cost pressures and supply chain risks in the medtech sector. As such, tariff pressures could accelerate supply chain diversification and […]